Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by 11runner11on May 08, 2020 1:19pm
124 Views
Post# 31004078

Remember

Remember

“We are collaborating with over 200 customers on solutions for COVID-19 in three categories: diagnosis, vaccine development, and manufacturing treatment options,” he said. “On diagnostics, we are, for example, working with Sona Nanotechnology for rapid testing and Avacta to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening. Our work with the University of Queensland aims to speed manufacture of a trial vaccine. Many of our products are used in the development and manufacturing of vaccines, either biotechnologically produced vaccines or modern mRNA vaccines.  We ensure delivery to these customers with high priority."


This was posted before. But he says "they are working with Sona for rapid test and Avacta to DEVELOP and manufacture....

they are collaborating with 200 but the first one he mentions is Sona. They have the product and he know it back then. My guess is when it comes out they already have everything ready for mass production. Most bios take 2-4 years to make the money that is possible with this stock. We're waiting a month or two from a few weeks ago.It will come out.... be patient and ignore the shorts/ penny flippers.


GLTA Cheers



 

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse